Market

Market & patent

Significant Market Opportunity in Research Institutions

The demand for advanced diagnostics in healthcare is rapidly increasing, driven by rising healthcare spending, growing needs in Academic Medical Centers (AMCs), and government initiatives supporting medical research. The Research institutions and AMCs represent a key market opportunity, with fewer regulatory barriers and a clear path to revenue generation. There is a critical need for early diagnosis in neonatal care and breast cancer, where traditional methods often fail. In neonatal care, the growing prevalence of preterm births and birth asphyxia highlights the urgent need for advanced, non-invasive diagnostic tools to enable timely interventions. Similarly, in breast cancer diagnostics, the need for early detection remains critical, but existing methods like mammography often lack real-time, comprehensive imaging of key functional parameters such as tissue oxygenation.

Deep Light Vision’s Ultrasound Optical Tomography Product Positioning:

Real-Time Oxygenation Imaging: Provides deep tissue and real-time oxygenation imaging of tissues, enabling faster, more informed decisions for early intervention.
Non-Invasive and Radiation-Free: Safer for neonatal care and cancer diagnosis, with no radiation that can negatively impact involved patients and staff.
Cost-Effective and Scalable: More affordable long term with modular configurations that are suitable for both developed and emerging markets.

Go to market strategy:

DLV will launch the UOT system in phases, starting with a research-use only (RUO) version, FDA-approved and CE-marked, for clinical trials and early adopters, followed by a full commercial launch. This phased approach will enable clinical validation and user feedback to refine the technology.

Medical applications - potential advantages

Neonatal

breast cancer

stroke

heart attack

CHALLENGES WITH TODAY'S IMAGING TECHNIQUES

Current technologies face key limitations: shallow imaging depth less than a few centimeters, contrast agent dependency, radiation exposure, and high costs. UOT disrupts the market by offering:

6cm in reflectance mode and 10cm in transmission penetration with ultrasound tagging.
Intrinsic oxygenation contrast without contrast agents.
Real-time oxygenation mapping eliminating radiation risks.
Cost-effective design ideal for neonatal and broader clinical applications.

These advantages position UOT as a disruptive technology in the medical imaging market, with opportunities for strategic partnerships, improved patient outcomes, and broader accessibility.

NEW AND POTENTIALLY GROUND-BREAKING TECHNOLOGY

Ultrasound Optical Tomography (UOT) is a new and potentially ground-breaking technology in medical imaging alongside the traditional methods. In addition to cancer and emergency diagnostics, there are a number of possible applications of the technology for, for example, monitoring treatment response, diagnostics in non-acute conditions, and in sports medicine.

Our assessment is that the technology has the potential to revolutionize the market, and create a new use on a broad front within healthcare in a number of areas.

patents

Two patent applications have been filed to protect the technology internationally. The patent applications cover technical solutions in a UOT system. The patent applications have been examined in the international phase (PCT) and will proceed for examination in the national phase in the countries and continents that represent the most important and largest markets.

The company intends to seek further patent protection for technical solutions that will be used in the research system that is now under development.